Mo Yin

🌍Attention ACORN2 and ACORN-HAI sites! 📊We're launching the ACORN-HAI-LITE survey to improve antimicrobial surveillance. Your feedback is key! Participate now: nus.syd1.qualtrics.com/jfe/form/SV_8b…

Exciting news! 🎉 NUS launches its Master's in Infectious Disease Emergencies in July/Aug 2025. Tailored coursework, hybrid learning, and networking opportunities await! Make an impact! 🌍💼 Register here👉forms.office.com/pages/response… #InfectiousDiseases #NUS

Reached over 3000 recruited cases after the 1st study year !!! Look who we are ? 👀 We are “Advance ID” network from Asia 🦠🧫🧬🩺💊 @ADVANCE__ID @davidantibiotic @InfectiousMoYin

The burden and dynamics of hospital-acquired SARS-CoV-2 in England. Relieved to see this finally out: nature.com/articles/s4158… with @_StephanieEvans @thimui_pham @JVRobotham @gmknght @InfectiousMoYin @cherrylimxq @markgpritchard @drdavideyre @JonRead15 @PeterHorby @sbfnk et al

An ambitious 3-year Global Convening Programme supported by the @BritishAcademy_ on “Just transitions for Antimicrobial resistance (AMR)” - bit.ly/3YkK9gY #scicomm #publicengagement

Just transition gained much prominence in climate governance. #JustTransition should also help us put equity and justice at the heart of planning for a future with #antimicrobial resistance. Read our new comment in @TheLancet #JT4AMR thelancet.com/journals/lance…

Are you a superhero🦸managing superbugs🦠? Share your secrets in our global survey!! redcap.link/advanceidgloba… to discover management practices against carbapenem-resistant Gram-negative infections. Join us in the fight against AMR.💪#AMR #StopSuperbugs #theAMRnarrative #IDtwitter

We're proud to fund @ADVANCE__ID, a network of over 50 hospitals fighting drug-resistant infections in Asia. Find out more in our latest "Behind the Research" newsletter: linkedin.com/pulse/how-coll…

"Developing new antibiotics is especially challenging" @InfectiousMoYin outlines why.

#Collaboration and #transparency are pivotal to maximizing benefit from research. In today’s #GoodTrialsGrapevine, @InfectiousMoYin of @ADVANCE__ID discusses the benefits of collaboration to boost the efficiency & quality of #clinicaltrials in Asia. 👉lnkd.in/e6TCZ-Ue

Oh, and here’s a summary of the work in the style of Cormac McCarthy (er…thanks chatGPT). Not sure why more journals don’t routinely ask fo this. 🌵

So happy to see this paper finally out journals.plos.org/plosmedicine/a… (wonderful collaborative work with @InfectiousMoYin, Mathupanee Oonsivilai, @cherrylimxq and @NeneRiehus that started life as an away day team-building exercise in a Bangkok cafe)

This World Antimicrobial Awareness Week, we’ll learn about a clinical trial network based in Asia that aims to improve regional clinical research for infectious diseases. Dr @InfectiousMoYin will tell us more in our next #TwitterSpace. Reply with your questions👇